Home › Brain Tumors › NCT04427384
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria:
1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.
2. Willing and able to provide informed consent and to participate in all evaluations.
Exclusion Criteria:
1. Inability to undergo pre-operative and post-operative imaging for disease and implant assessment.
2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.
3. Subjects who, in the investigator's opinion, are unable to understand the protocol or to give informed consent, have a history of poor cooperation, noncompliance with medical treatment, or difficulty in returning for follow up care. A legally authorized representative may provide consent if the potential subject lacks the capacity to provide consent themselves.
About the study
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
What is being tested
Sponsor: GT Medical Technologies, Inc. · Participants: 600 · Started: Sep 11, 2020
Contact the study team
Official record on ClinicalTrials.gov — NCT04427384
Locations in the U.S.
| Arizona | HonorHeath Scottsdale Osborn Medical Center, Phoenix |
| Arkansas | University of Arkansas Medical Center, Little Rock |
| California | Eden Medical Center, Castro Valley UCSD Moores Cancer Center, La Jolla MemorialCare Health System, Laguna Hills Desert Regional Medical Center, Palm Springs California Pacific Medical Center, Sutter health, San Francisco |
| Colorado | Centura, Denver (Not yet recruiting) Colorado Brain & Spine Institute: Swedish Campus, Englewood |
| Florida | BayCare Health, Clearwater Ascension St. Vincent's, Jacksonville Miami Cancer Institute, Baptist Health South Florida, Miami Advent Health Orlando, Orlando Orlando Health, Orlando Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital, Tampa Cleveland Clinic Florida- Weston, Weston |
| Georgia | Piedmont Healthcare, Atlanta Winship Cancer Institute of Emory University, Atlanta |
| Idaho | St. Alphonsus Regional Medical Center, Boise |
| Indiana | Goodman Campbell Brain and Spine, Carmel Indiana University, IU Health Methodist Hospital, Indianapolis |
| Kansas | KUMC Dept of Neurosurgery, Kansas City |
| Kentucky | Norton Cancer Institute, Louisville Univeristy of Louisville Health, Louisville |
| Massachusetts | Beth Israel Deaconess Medical Center, Boston Beth Israel Deaconess Medical Center, Boston |
| Michigan | Henry Ford Health System, Detroit |
| Minnesota | Abbott Northwestern Hospital, Minneapolis University of Minnesota, Minneapolis |
| Nebraska | University of Nebraska, Omaha |
| New Jersey | Clinical Research dep. Davison Place. Englewood Health, Englewood (Not yet recruiting) |
| New York | Albany Medical Center, Albany SUNY Upstate Medical Center, Syracuse Montefiore Einstein, The Bronx Westchester Medical Center, Valhalla |
| North Carolina | Vidant Heath - ECU Medical Center, Greenville Atlantic Brain & Spine, Wilmington |
| Ohio | Mayfield Brain and Spine, Cincinnati Kettering Health, Kettering |
| Pennsylvania | St Luke's University Health, Sacred Heart Campus, Allentown Penn State Health, Hershey Allegheny Health Network, Pittsburgh |
| Rhode Island | Brown University Health, Providence |
| Tennessee | CHI Memorial Hospital, CommonSpirit, Chattanooga |
| Texas | UT Southwestern Simmons Cancer Center, Dallas Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston Houston Methodist Hospital, Houston University of Texas Health Science Center of San Antonio, San Antonio Texas Oncology-The Woodlands, The Woodlands |
| Virginia | INOVA Health, Fairfax |
| Washington | Virginia Mason, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.